Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...
America is in the midst of a pharmacy crisis, and the Food and Drug Administration could make it much worse. Hundreds of ...
The GLP-1 fight just entered a new round, and it highlights why these three out-of-favor drug makers are worth a deep dive.
Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...
Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.
For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.
Excessive prescription refilling by mail-order pharmacies leaves piles of unneeded pills. “Every time, there are 15 extra ...
JEFFERSON CITY, Mo. (KCTV) - Missouri lawmakers have filed multiple bills to regulate pharmacy benefit managers and lower prescription drug prices for patients. The Missouri Pharmacy Business Council ...
The Chosun Ilbo on MSN
Pharmaceutical industry demands drug price policy reconsideration
The pharmaceutical and biotech industry could suffer annual losses of up to 3.6 trillion won if a policy cutting generic drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results